BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 8278585)

  • 1. Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland.
    Stone HB; Brown JM; Phillips TL; Sutherland RM
    Radiat Res; 1993 Dec; 136(3):422-34. PubMed ID: 8278585
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical development and current status of the fluorinated 2-nitroimidazole hypoxia probe N-(2-hydroxy-3,3,3-trifluoropropyl)-2-(2-nitro-1-imidazolyl) acetamide (SR 4554, CRC 94/17): a non-invasive diagnostic probe for the measurement of tumor hypoxia by magnetic resonance spectroscopy and imaging, and by positron emission tomography.
    Aboagye EO; Kelson AB; Tracy M; Workman P
    Anticancer Drug Des; 1998 Sep; 13(6):703-30. PubMed ID: 9755726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carbon beam therapy overcomes the radiation resistance of uterine cervical cancer originating from hypoxia.
    Nakano T; Suzuki Y; Ohno T; Kato S; Suzuki M; Morita S; Sato S; Oka K; Tsujii H
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2185-90. PubMed ID: 16609033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head and neck cancer: the importance of oxygen.
    Terris DJ
    Laryngoscope; 2000 May; 110(5 Pt 1):697-707. PubMed ID: 10807350
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.
    Lunsford LD; Flickinger JC; Larson D
    Oncologist; 1997; 2(1):59-61. PubMed ID: 10388030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endogenous markers of tumor hypoxia predictors of clinical radiation resistance?
    Vordermark D; Brown JM
    Strahlenther Onkol; 2003 Dec; 179(12):801-11. PubMed ID: 14652668
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 31P nuclear magnetic resonance spectroscopy studies of tumor energy metabolism and its relationship to intracapillary oxyhemoglobin saturation status and tumor hypoxia.
    Rofstad EK; DeMuth P; Fenton BM; Sutherland RM
    Cancer Res; 1988 Oct; 48(19):5440-6. PubMed ID: 3416301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Development of new methods of magnetic resonance for the characterization of oxygenation and perfusion of tumors. Diagnostic and therapeutic applications].
    Gallez B
    Bull Mem Acad R Med Belg; 2007; 162(5-6):323-30. PubMed ID: 18405002
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix.
    Hockel M; Schlenger K; Aral B; Mitze M; Schaffer U; Vaupel P
    Cancer Res; 1996 Oct; 56(19):4509-15. PubMed ID: 8813149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oxygenation of spontaneous canine tumors during fractionated radiation therapy.
    Achermann RE; Ohlerth SM; Rohrer Bley C; Gassmann M; Inteeworn N; Roos M; Schärz M; Wergin MC; Kaser-Hotz B
    Strahlenther Onkol; 2004 May; 180(5):297-305. PubMed ID: 15127160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of RSR13, an allosteric hemoglobin modifier, on oxygenation in murine tumors: an in vivo electron paramagnetic resonance oximetry and bold MRI study.
    Hou H; Khan N; O'Hara JA; Grinberg OY; Dunn JF; Abajian MA; Wilmot CM; Makki M; Demidenko E; Lu S; Steffen RP; Swartz HM
    Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):834-43. PubMed ID: 15183487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of tumor oxygenation by electron paramagnetic resonance: principles and applications.
    Gallez B; Baudelet C; Jordan BF
    NMR Biomed; 2004 Aug; 17(5):240-62. PubMed ID: 15366026
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relation between pO2, 31P magnetic resonance spectroscopy parameters and treatment outcome in patients with high-grade soft tissue sarcomas treated with thermoradiotherapy.
    Dewhirst MW; Poulson JM; Yu D; Sanders L; Lora-Michiels M; Vujaskovic Z; Jones EL; Samulski TV; Powers BE; Brizel DM; Prosnitz LR; Charles HC
    Int J Radiat Oncol Biol Phys; 2005 Feb; 61(2):480-91. PubMed ID: 15667971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radiation sensitizers: with special reference to hypoxic cell sensitizers].
    Onoyama Y; Nakajima T; Tanaka M
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):894-903. PubMed ID: 3963856
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hypoxia and radiotherapy: opportunities for improved outcomes in cancer treatment.
    Moeller BJ; Richardson RA; Dewhirst MW
    Cancer Metastasis Rev; 2007 Jun; 26(2):241-8. PubMed ID: 17440683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cervical cancer regression measured using weekly magnetic resonance imaging during fractionated radiotherapy: radiobiologic modeling and correlation with tumor hypoxia.
    Lim K; Chan P; Dinniwell R; Fyles A; Haider M; Cho YB; Jaffray D; Manchul L; Levin W; Hill RP; Milosevic M
    Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):126-33. PubMed ID: 17768016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Restoration of tumor oxygenation after cytotoxic therapy by a perflubron emulsion/carbogen breathing.
    Teicher BA; Holden SA; Ara G; Dupuis NP; Goff D
    Cancer J Sci Am; 1995; 1(1):43-8. PubMed ID: 9166453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term performance of interstial fluid pressure and hypoxia as prognostic factors in cervix cancer.
    Fyles A; Milosevic M; Pintilie M; Syed A; Levin W; Manchul L; Hill RP
    Radiother Oncol; 2006 Aug; 80(2):132-7. PubMed ID: 16920212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic impact of reoxygenation in advanced cancer of the head and neck during the initial course of chemoradiation or radiotherapy alone.
    Dietz A; Vanselow B; Rudat V; Conradt C; Weidauer H; Kallinowski F; Dollner R
    Head Neck; 2003 Jan; 25(1):50-8. PubMed ID: 12478544
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Taking advantage of tumor cell adaptations to hypoxia for developing new tumor markers and treatment strategies.
    Ebbesen P; Pettersen EO; Gorr TA; Jobst G; Williams K; Kieninger J; Wenger RH; Pastorekova S; Dubois L; Lambin P; Wouters BG; Van Den Beucken T; Supuran CT; Poellinger L; Ratcliffe P; Kanopka A; Görlach A; Gasmann M; Harris AL; Maxwell P; Scozzafava A
    J Enzyme Inhib Med Chem; 2009 Apr; 24 Suppl 1():1-39. PubMed ID: 19330638
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.